- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Cardinal Health Inc(CAH)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for CAH
11/18/2026: CAH (5-star) is a STRONG-BUY. BUY for 25 days. Simulated Profits (9.70%). Updated daily EoD!
Cardinal Health Inc is a prominent healthcare services and products company operating as a core distributor of pharmaceuticals and medical supplies. The company benefits from a resilient business model, entrenched customer relationships, and a vital position within the US healthcare supply chain, though it operates on traditionally thin distribution margins. Its primary investment story centers on steady cash flow generation, operational turnarounds in the medical segment, and expansion into high-growth specialty therapeutics. Key risks include intense oligopolistic competition, potential drug pricing reform, and cost pressures in healthcare logistics. The stock suits defensive income and value investors monitoring ongoing margin execution and specialty growth catalysts.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | Cardinal Health offers steady, predictable growth rather than rapid expansion. |
| Momentum investor | Strong fit while signal remains positive | Momentum fit is conditional on positive price trends and a strong technical breakout signal. |
| Value investor | Strong fit | The stock frequently trades at reasonable valuation multiples relative to its stable cash flows. |
| Dividend investor | Strong fit | The company has a reliable history of consistent dividend payments and shareholder return commitments. |
| Low-risk investor | Strong fit | Defensive healthcare demand profile provides lower relative volatility compared to cyclical sectors. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Low | As a defensive healthcare distributor, the stock generally experiences lower volatility than broader market indices. |
| Valuation risk | Low | Modest valuation multiples limit downside risk from multiple contraction. |
| Competition risk (oligopoly distribution market) | Medium | Intense competition with McKesson and Cencora keeps pressure on distribution contract renewals and margins. |
| Business quality | Strong | Essential role in the healthcare supply chain underpins durable operational franchise quality. |
| Dividend income | Medium | Provides steady cash returns, though dividend growth rates are generally conservative. |
| Execution risk | Medium | Margin recovery in the medical segment and management of complex logistics networks require ongoing operational discipline. |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 64.54B USD | Price to earnings Ratio 36.13 | 1Y Target Price 300.8 |
Price to earnings Ratio 36.13 | 1Y Target Price 300.8 | ||
Volume (30-day avg) 1.7M shares | Beta 0.52 | 52 Weeks Range 179.64 - 286.29 | Updated Date 11/18/2026 |
52 Weeks Range 179.64 - 286.29 | Updated Date 11/18/2026 | ||
Dividends yield (FY) 0.72% | Basic EPS (TTM) 7.73 |
Sector & Industry Intelligence
Sector
Healthcare
Constructive- Sentiment
- Strong Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 62.3%
- Active BUY / eligible
- 66 / 106
- 30-Day BUY Count Change
- +23
- Market state
- Strong Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Medical Distribution
- BUY participation
- 100.0%
- Active BUY / eligible
- 3 / 3
- 30-Day BUY Count Change
- 0
Eligible universe: 3 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Smooth
The stock has moved along a generally orderly path with only modest fluctuations.
Analysis of Past Performance
Type Stock | Historic Profit 92.69% | Avg. Invested days 53 | Today’s Advisory Strong Buy |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Pharmaceutical Distribution | Wholesale distribution of brand, generic, and specialty prescription drugs to hospitals, retail chains, and independent pharmacies. | This is the primary revenue engine, generating massive sales volume but operating on very thin profit margins. |
| Medical Products | Manufacture and distribution of Cardinal Health brand medical and surgical supplies, laboratory products, and procedural solutions. | Provides product-level diversification and higher potential margin contributions compared to pure pharmaceutical distribution. |
| Pharmaceutical Solutions and Nuclear Pharmacy | Specialty pharmacy logistics, data solutions, and the preparation and delivery of radiopharmaceuticals. | Serves as a high-value, specialized niche segment that supports overall profitability and market differentiation. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-11-05 | When Before Market | Estimate 2.92 | Actual 3.26 |
Profitability
Profit Margin 0.7% | Operating Margin (TTM) 1.33% |
Management Effectiveness
Return on Assets (TTM) 3.72% | Return on Equity (TTM) - |
Valuation
Trailing PE 36.13 | Forward PE 21.93 | Enterprise Value 69.16B | Price to Sales(TTM) 0.25 |
Enterprise Value 69.16B | Price to Sales(TTM) 0.25 | ||
Enterprise Value to Revenue 0.27 | Enterprise Value to EBITDA 19.35 | Shares Outstanding 231.14M | Shares Floating 230.70M |
Shares Outstanding 231.14M | Shares Floating 230.70M | ||
Percent Insiders 0.32 | Percent Institutions 90.37 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

